Abstract
Balloon aortic valvuloplasty (BAV) was originally considered as an alternative to surgery for the treatment of aortic stenosis. However, due to the poor durability of its effects, it was largely relegated to palliative use. Recently, there has been increased application of BAV, particularly as a bridging procedure to transcatheter aortic valve replacement (TAVR) therapy. Furthermore, stand-alone BAV is now more frequently employed as palliative procedure for the growing population of older adults with aortic stenosis (AS) with limited life expectancy. Accordingly, BAV use has increased both in the USA and other countries, and this trend is expected to continue. The purpose of this review is to document trends in BAV use, data on effectiveness, and considerations in frail older adults in contemporary medical practice.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
